Joellen Martha Schildkraut

Professor Emeritus in Family Medicine and Community Health
6036 Hock Plaza, 2424 Erwin Road, Durham, NC 27705
(919) 681-4761
joellen.schildkraut@duke.edu

Dr. Schildkraut is an epidemiologist whose research includes the molecular epidemiology of ovarian, breast and brain cancers. Dr. Schildkraut's research interests include the study of the interaction between genetic and environmental factors. She is currently involved in a large study of genome wide association and ovarian cancer risk and survival. Some of her work is also focused on particular genetic pathways including the DNA repair and apoptosis pathways. She currently leads a study of African American women diagnosed with ovarian cancer. She is also collaborating in a large a case-control study of meningioma risk factors and with which a genome wide association analysis is about to commence.

Education and Training

  • Yale University, M.P.H. 1982
  • Yale University, Ph.D. 1987

Selected Grants and Awards

Publications

Displaying 1 - 10 of 379
Saunders CN, Cornish AJ, Kinnersley B, Law PJ, Claus EB, Il’yasova D, et al. Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis. Neuro Oncology. 2020 Feb;22(2):207–15.
Peres LC, Schildkraut JM. Racial/ethnic disparities in ovarian cancer research. In: Advances in Cancer Research. 2020.
Sjöberg RL, Wu WY-Y, Dahlin AM, Tsavachidis S, Gliogene Group, Bondy ML, et al. Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study.. Journal of Neuro Oncology. 2019 Nov;145(2):287–94.
Jiang X, Dimou NL, Al-Dabhani K, Lewis SJ, Martin RM, Haycock PC, et al. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study.. Int J Epidemiol. 2019 Oct 1;48(5):1416–24.
Peres LC, Hebert JR, Qin B, Guertin KA, Bandera EV, Shivappa N, et al. Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma.. J Nutr. 2019 Sep 1;149(9):1606–16.
Manichaikul A, Peres LC, Wang X-Q, Barnard ME, Chyn D, Sheng X, et al. Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.. Int J Cancer. 2019 Aug 30;
Reid BM, Permuth JB, Chen YA, Fridley BL, Iversen ES, Chen Z, et al. Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.. Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1117–26.
Schildkraut JM, Peres LC, Bethea TN, Camacho F, Chyn D, Cloyd EK, et al. Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.. Cancer Causes Control. 2019 Jun 24;
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Australian Ovarian Cancer Study Group, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.. Int J Epidemiol. 2019 Jun 1;48(3):822–30.
Takahashi H, Cornish AJ, Sud A, Law PJ, Kinnersley B, Ostrom QT, et al. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma.. Sci Rep. 2019 May 23;9(1).

Pages